TRIUMPH-1

Advertisement

cGxPJobs Banner

Lilly Unveils Landmark Phase 3 Data for Foundayo and Retatrutide at ADA 2026

INDIANAPOLIS, May 28, 2026 Eli Lilly and Company has announced a major slate of scientific presentations for the American...

By cGxPwire Editor
May 30, 2026

Read More

Eli Lilly Retatrutide Phase 3 Trial Delivers Major Weight Loss

INDIANAPOLIS, May 21, 2026 Eli Lilly and Company announced positive topline results from its pivotal Phase 3 TRIUMPH-1 clinical...

By cGxPwire Editor
May 22, 2026

Read More

Advertisement

cGxPJobs

Directory